Brandon Sheffield, MD | Authors

Brandon Sheffield, MD, Details NGS Benefits Vs Single-Gene Testing in NSCLC

August 09, 2022

At the 2022 WCLC, Brandon Sheffield, MD, presented data demonstrating the advantage of next-generation sequencing over other biomarker testing strategies in patients with non–small cell lung cancer.